Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Associate

James Oh

Goodwin Procter

main

Oh James

Goodwin Associate James Oh, from Santa Monica, practices in ERISA & Executive Compensation.

James Oh

Areas of Practice

Professional Experience

Credentials

Education

JD2019

BS2015

Admissions

Bars

Related Content

Astera Labs Completes Upsized $774 Million Initial Public Offering

AVROBIO To Combine With Tectonic Therapeutic In All-Stock Transaction

Renesas to Acquire Transphorm in $339 Million Transaction

Goodwin Advises Thoma Bravo on $1.8 Billion Acquisition of NextGen Healthcare, Inc.

Thoma Bravo To Acquire NextGen Healthcare

Quince Therapeutics To Acquire EryDel SpA In Stock-For-Stock Transaction With Up To $485 Million In Potential Downstream Milestones

GreenLight Biosciences to be Acquired in a Go-Private Transaction by a Consortium Led by Fall Line Endurance Fund

TCR² Therapeutics and Adaptimmune Enter Into Strategic Combination To Create A Preeminent Cell Therapy Company For Solid Tumors

ERISA & Executive Compensation

James Oh

Areas of Practice

Professional Experience

Credentials

Education

JD2019

BS2015

Admissions

Bars

Related Content

Astera Labs Completes Upsized $774 Million Initial Public Offering

AVROBIO To Combine With Tectonic Therapeutic In All-Stock Transaction

Renesas to Acquire Transphorm in $339 Million Transaction

Goodwin Advises Thoma Bravo on $1.8 Billion Acquisition of NextGen Healthcare, Inc.

Thoma Bravo To Acquire NextGen Healthcare

Quince Therapeutics To Acquire EryDel SpA In Stock-For-Stock Transaction With Up To $485 Million In Potential Downstream Milestones

GreenLight Biosciences to be Acquired in a Go-Private Transaction by a Consortium Led by Fall Line Endurance Fund

TCR2 Therapeutics and Adaptimmune Enter Into Strategic Combination To Create A Preeminent Cell Therapy Company For Solid Tumors

TCR² Therapeutics and Adaptimmune Enter Into Strategic Combination To Create A Preeminent Cell Therapy Company For Solid Tumors